Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UNIPROT:P17174 (aspartate aminotransferase)
 14,872 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

We measured the activity of carnosinase, a prominent hepatic peptidase, in sera from 69 patients with liver disorders. Mean values (and SDs) for those with liver cirrhosis (17 cases) and hepatoma (seven cases) were 0.51 (0.28) and 0.68 (0.21) mumol/mL per hour, respectively--clearly less than for normal adults: 4.19 (0.95) mumol/mL per hour. Samples from 17 cases of chronic hepatitis also showed moderately decreased activity, 1.41 (0.97) mumol/mL per hour. In contrast, 14 cases of acute hepatitis generally showed values falling within the normal limits: 3.41 (1.97) mumol/mL per hour. Our results for carnosinase correlated with those for cholinesterase (r = 0.70) and with the concentration of albumin in serum (r = 0.59), but not with the activity of either creatine kinase, aspartate aminotransferase, or alanine aminotransferase in serum. Carnosinase values differed more among groups of disorders than did the values for cholinesterase or albumin. Measurement of serum carnosinase activity may be of clinical value in assessing the severity of chronic liver-cell damage, but not in differentiating liver disease from nutritional, muscle, or endocrine disorders.
 ...
PMID:Decreased activity of carnosinase in serum of patients with chronic liver disorders. 373 53

This study was undertaken as part of a larger investigation into carnosine metabolism and function in the Thoroughbred horse. More specifically, we wished to evaluate plasma carnosine concentration as a potential indicator of muscle carnosine status. In contrast to man, carnosine is present in equine plasma where its presence is consistent with the absence of plasma carnosinase. A significant effect of age on plasma carnosine concentration in resting Thoroughbred horses was observed. Values in horses age 3 years and older were 113-14.1 micromol/l, whereas concentrations in foals and yearlings were 3.9-8.7 micromol/l (P<0.001). Lower values in young horses may reflect lower skeletal muscle carnosine concentrations. There was no significant within-day variation in plasma carnosine concentration in fed and fasted horses (P>0.05). Intense exercise resulted in a small significant increase (P<0.05) in plasma carnosine concentration (pre-exercise, 10.3 +/- 1.0 micromol/l; postexercise, 12.4 +/- 4.4 micromol/l). Greater increases were observed (57.6-702.3 micromol/l) following onset of exercise-induced rhadomyolysis (ERS). An apparent relationship was observed between elevated plasma carnosine and increased plasma creatine kinase (CK) and aspartate transaminase (AST) activities. Plasma carnosine concentrations did not reflect the severity of the condition as determined by clinical examination. In conclusion, elevated plasma carnosine levels are observed following exercise induced muscle damage, with the greatest elevations occurring during episodes of external rhabdomylosis syndrome. Plasma carnosine measurements could provide an alternative clinical indicator of muscle damage; and in conjunction with plasma taurine measurements may be indicative of selective type 1 or type 2 muscle fibre damage. However, given the complexity of the analytical technique, its applications would probably be confined to specialist referral or research centres.
 ...
PMID:Plasma carnosine concentration: diurnal variation and effects of age, exercise and muscle damage. 1240 2